Yahoo Canada Web Search

Search results

  1. 4 days ago · Vera stock catapulted and broke out on Monday after unveiling promising results for its kidney disease treatment. ... meaning they rank in the leading 3% of all stocks when it comes to 12-month ...

  2. 5 days ago · Vera Therapeutics (VERA) announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $300M of shares of its Class A common stock. All of the shares ...

  3. BRISBANE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $300.0 million of shares of its ...

  4. 4 days ago · In connection with the proposed offering, Vera expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Class A common stock sold in the public ...

  5. 4 days ago · Should You Buy or Sell Vera Therapeutics Stock? Get The Latest VERA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

  6. Find the latest Vera Therapeutics, Inc. (VERA) stock quote, history, news and other vital information to help you with your stock trading and investing.

  7. People also ask

  8. Jan 25, 2024 · Vera Therapeutics, Inc. stock price soared over 35% today as it announced positive results from the open label extension of its Phase 2b ORIGIN clinical trial for atacicept in IgA nephropathy....

  1. People also search for